Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
December 9, 2016
New treatments for bladder cancer
Noah M Hahn
The Journal of Urology
|
March 17, 2009
Learning to control cyclophosphamide induced cystitis
Noah M Hahn
Hematology/Oncology Clinics of North America
|
April 19, 2005
Combined chemoradiotherapy in small cell lung cancer
Noah M Hahn, Nasser Hanna
Asian Journal of Andrology
|
April 10, 2014
Heat shock and other apoptosis-related proteins as therapeutic targets in prostate cancer
Costantine Albany, Noah M Hahn
Urologic Oncology
|
July 16, 2005
Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease
Noah M Hahn, Christopher J Sweeney
Urologic Oncology
|
October 25, 2016
Emerging role of immunotherapy in urothelial carcinoma-Future directions and novel therapies
Jong Chul Park, Noah M Hahn
Clinical Advances in Hematology & Oncology : H&O
|
February 13, 2015
Bladder cancer: a disease ripe for major advances
Jong Chul Park, Noah M Hahn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select
Charles G Drake, Trinity J Bivalacqua, Noah M Hahn
Human Vaccines & Immunotherapeutics
|
July 27, 2012
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
Thomas A Gardner, Bennett D Elzey, Noah M Hahn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2015
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Ali Ghasemzadeh, Trinity J Bivalacqua, Noah M Hahn, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
Clinical Advances in Hematology & Oncology : H&O
|
December 9, 2016
New treatments for bladder cancer
Noah M Hahn
The Journal of Urology
|
March 17, 2009
Learning to control cyclophosphamide induced cystitis
Noah M Hahn
Hematology/Oncology Clinics of North America
|
April 19, 2005
Combined chemoradiotherapy in small cell lung cancer
Noah M Hahn, Nasser Hanna
Asian Journal of Andrology
|
April 10, 2014
Heat shock and other apoptosis-related proteins as therapeutic targets in prostate cancer
Costantine Albany, Noah M Hahn
Urologic Oncology
|
July 16, 2005
Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease
Noah M Hahn, Christopher J Sweeney
Urologic Oncology
|
October 25, 2016
Emerging role of immunotherapy in urothelial carcinoma-Future directions and novel therapies
Jong Chul Park, Noah M Hahn
Clinical Advances in Hematology & Oncology : H&O
|
February 13, 2015
Bladder cancer: a disease ripe for major advances
Jong Chul Park, Noah M Hahn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select
Charles G Drake, Trinity J Bivalacqua, Noah M Hahn
Human Vaccines & Immunotherapeutics
|
July 27, 2012
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
Thomas A Gardner, Bennett D Elzey, Noah M Hahn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2015
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Ali Ghasemzadeh, Trinity J Bivalacqua, Noah M Hahn, et al.
Page
of 14